Subject demographics (for example: age, sex, self-identified race), lab values (for example: HbA1c, BMI, liver enzymes), and some medication information (GLP-1 M, other drugs used to treat T2D, and NSAIDs) and presence or absence of diabetes-associated complications (for example: chronic kidney disease, cardiovascular disease) were extracted as prediction features
[6] When gathering your skin, do not gather any muscle tissue
Lifestyle factors, adherence to dosing, and your bodys unique chemistry all play a role in your weight loss journey Side Effects & Safety Both medications have similar side effects, including: Nausea, vomiting, and diarrhea Decreased appetite Potential blood sugar changes However, some patients report that Tirzepatide has a higher likelihood of gastrointestinal side effects in the early weeks of treatment
Prefer non-invasive treatments that are easy to incorporate into their routine
Tirzepatide (highest doses in SURMOUNT-1) produced average losses near or above 20%, depending on dose, with clear dose-response effects in pivotal trials